Patents by Inventor Shuyuan Ma

Shuyuan Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240117447
    Abstract: Disclosed herein are primers and probes related to the detection of Neisseria gonorrhoeae via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of N. gonorrhoeae nucleic acids present in test samples. Specifically the present disclosure describes primers and probes that bind to the small subunit rRNA (cytosine (967)-C(5))-methyltransferase or rsmB gene of N. gonorrhoeae for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.
    Type: Application
    Filed: April 6, 2023
    Publication date: April 11, 2024
    Inventors: Andrea DEDENT, Shuyuan MA, Hedia MAAMAR
  • Publication number: 20230073971
    Abstract: The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.
    Type: Application
    Filed: April 11, 2022
    Publication date: March 9, 2023
    Inventors: Andrea DEDENT, Matt LEE, Shuyuan MA, Hedia MAAMAR
  • Patent number: 11326214
    Abstract: The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: May 10, 2022
    Assignee: Talis Biomedical Corporation
    Inventors: Andrea Dedent, Matt Lee, Shuyuan Ma, Hedia Maamar
  • Publication number: 20210301325
    Abstract: The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.
    Type: Application
    Filed: May 9, 2019
    Publication date: September 30, 2021
    Inventors: Daniel CAPULE, Andrea DEDENT, Matt LEE, Shuyuan MA, Hédia MAAMAR, Dana Kelly VANATTA
  • Publication number: 20200002752
    Abstract: The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 2, 2020
    Inventors: Andrea DEDENT, Matt LEE, Shuyuan MA, Hedia MAAMAR
  • Publication number: 20190345541
    Abstract: The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 14, 2019
    Inventors: Andrea DEDENT, Matt LEE, Shuyuan MA, Hédia MAAMAR
  • Patent number: 10450616
    Abstract: The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: October 22, 2019
    Assignee: Talis Biomedical Corporation
    Inventors: Andrea Dedent, Matt Lee, Shuyuan Ma, Hédia Maamar
  • Publication number: 20190284618
    Abstract: Disclosed herein are primers and probes related to the detection of Neisseria gonorrhoeae via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of N. gonorrhoeae nucleic acids present in test samples. Specifically the present disclosure describes primers and probes that bind to the small subunit rRNA (cytosine (967)-C(5))-methyltransferase or rsmB gene of N. gonorrhoeae for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.
    Type: Application
    Filed: November 13, 2017
    Publication date: September 19, 2019
    Inventors: Andrea C. Dedent, Shuyuan Ma, Hedia Maamar